Chardon Benoit 4

4 · ALLURION TECHNOLOGIES, INC. · Filed Dec 14, 2023

Form 4

Period: 2023-12-12

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
2023-12-12$1.13/sh+97,799$110,513→ 131,443 total
Exercise/Conversion
Common Stock
2023-12-12$1.17/sh+23,939$28,009→ 155,382 total
Exercise/Conversion
Common Stock
2023-12-12$0.95/sh+25,060$23,807→ 180,442 total
Exercise/Conversion
Common Stock
2023-12-12$1.88/sh+18,741$35,233→ 199,183 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−97,799→ 0 total
Exercise: $1.13Exp: 2028-08-21→ Common Stock (97,799 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−23,939→ 510 total
Exercise: $1.17Exp: 2030-03-04→ Common Stock (23,939 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−18,741→ 20,377 total
Exercise: $1.88Exp: 2031-12-06→ Common Stock (18,741 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-12-12−25,060→ 4,279 total
Exercise: $0.95Exp: 2030-12-28→ Common Stock (25,060 underlying)

Footnotes (5)

[F1]This option is fully vested.
[F2]This option shall vest and become exercisable in monthly installments over a period of 48 months from January 1, 2020, subject to the Reporting Person's continued service on each such vesting date.
[F3]25% of the shares underlying this option vested on July 1, 2021, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
[F4]25% of the shares underlying this option vested on January 1, 2023, and the remainder vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
[F5]Includes 14,669 shares that were inadvertently omitted from the Form 3 filed on August 1, 2023.

Documents

1 file